Diana Törmä

Diana Törmä

Auto-generated profile, based on publicly available information

Diana Törmä

A.I. Virtanen Institute University of Eastern Finland Kuopio Finland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2026 in APMIS
Verified
Journal Article
Open access
DTDiana Törmä
Diana Törmä
TSTuisku Suoranta
Tuisku Suoranta
MRMimmi Rinta‐Harri
Mimmi Rinta‐Harri
JHJarkko Hytönen
Jarkko Hytönen
SYSeppo Ylä‐Herttuala
Seppo Ylä‐Herttuala
ARAnna-Kaisa Ruotsalainen
Anna-Kaisa Ruotsalainen
Hypertension is a major contributor to cardiovascular diseases, being the most common comorbidity and the biggest risk factor in heart failure with preserved ejection fraction. Angiotensin II (Ang II) is a known hypertension and heart failure inducer in mice, but its role in the causality in phenotype development remains unclear. Here, hypertension was induced with low (LowA) or high (HighA) pressor doses of Ang II in mice. Both LowA and HighA groups demonstrated equal levels of hypertension with aortic dilatation and decreased aortic wall strain, but only HighA developed left ventricular hypertrophy with advanced cardiac dysfunction, demonstrating the hypertension‐independent effects of Ang II on myocardial remodeling. Alterations in electrical conductivity occurred similarly in both groups, with prominent ECG waveform aberrations. The study demonstrates two distinct hypertensive heart disease phenotypes induced by Ang II, providing a valuable preclinical framework that emphasizes the critical role of Ang II in diastolic dysfunction and vascular remodeling beyond its effects on the regulation of blood pressure.